Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer

Gynecologic Oncology

Volumn 140, Issue 1, 2016, Pages 124-130

  Kelemen, Linda E ^a,b,c   Warren, Graham W ^b,c   Koziak, Jennifer M ^a   Köbel, Martin ^d   Steed, Helen ^e  

^a ALBERTA HEALTH SERVICES   (Canada)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e Lois Hole Hospital for Women   (Canada)

Author keywords

Chemotherapy; Mucinous carcinoma; Ovarian neoplasms; Tobacco

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNIC GROUP; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; MINIMAL RESIDUAL DISEASE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; SMOKING; SMOKING CESSATION; TREATMENT DURATION; ADJUVANT CHEMOTHERAPY; ALBERTA; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MORTALITY; NEOADJUVANT THERAPY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

AGED; ALBERTA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; NEOADJUVANT THERAPY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SMOKING;

EID: 84951759360     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.11.008     Document Type: Article

References (26)

1. U.S. Department of Health and Human Services The Health Consequences of Smoking - 50 years of Progress: A Report of the Surgeon General 2014 U.S. Department of Health and Human Services Atlanta, GA (Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health)
2. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
3. G.W. Warren, S. Sobus, and E.R. Gritz The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support Lancet Oncol. 15 2014 e568 e580
4. American Cancer Society Cancer facts and figures 2015 Estimated New Cancer Cases and Deaths by Sex, US, All Sites, 2015 2015 American Cancer Society Atlanta, G.A.
5. W.P. McGuire 3rd. Current status of taxane and platinum-based chemotherapy in ovarian cancer J. Clin. Oncol. 21 2003 133s 135s
6. M.P. Coleman, D. Forman, H. Bryant, J. Butler, B. Rachet, C. Maringe, and et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 2011 127 138
7. M. Vessey, R. Painter, and D. Yeates Mortality in relation to oral contraceptive use and cigarette smoking Lancet 362 2003 185 191
8. L. Yang, A. Klint, M. Lambe, R. Bellocco, T. Riman, K. Bergfeldt, and et al. Predictors of ovarian cancer survival: a population-based prospective study in Sweden Int. J. Cancer 123 2008 672 679
9. B.D. Carter, C.C. Abnet, D. Feskanich, N.D. Freedman, P. Hartge, C.E. Lewis, and et al. Smoking and mortality - beyond established causes N. Engl. J. Med. 372 2015 631 640
10. C.M. Nagle, C.J. Bain, and P.M. Webb Cigarette smoking and survival after ovarian cancer diagnosis Cancer Epidemiol. Biomark. Prev. 15 2006 2557 2560
11. A. Kjaerbye-Thygesen, K. Frederiksen, E.V. Hogdall, E. Glud, L. Christensen, C.K. Hogdall, and et al. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer Cancer Epidemiol. Biomark. Prev. 15 2006 798 803
12. Y.J. Ioffe, R.G. Elmore, B.Y. Karlan, and A.J. Li Effect of cigarette smoking on epithelial ovarian cancer survival J. Reprod. Med. 55 2010 346 350
13. B. Rosen, S. Laframboise, S. Ferguson, J. Dodge, M. Bernardini, J. Murphy, and et al. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer Gynecol. Oncol. 134 2014 462 467
14. F.A. Tavassoulu, and P. Devilee World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs 2003 IARC Press Lyon
15. C.B. Gilks, D.N. Ionescu, S.E. Kalloger, M. Kobel, J. Irving, B. Clarke, and et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma Hum. Pathol. 39 2008 1239 1251
16. The Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
17. D.W. Hosmer, and S.L. Lameshow Applied Survival Analysis: Regression Modeling of Time to Event Data 1999 John Wiley & Sons, Inc New York
18. M. Kobel, S.E. Kalloger, N. Boyd, S. McKinney, E. Mehl, C. Palmer, and et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med. 5 2008 e232
19. M.T. Faber, S.K. Kjaer, C. Dehlendorff, J. Chang-Claude, K.K. Andersen, E. Hogdall, and et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies Cancer Causes Control 24 2013 989 1004
20. L.E. Kelemen, and M. Kobel Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma Lancet Oncol. 12 2011 1071 1080
21. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J. Clin. Oncol. 20 2002 1248 1259
22. S. Sandhu, G. Humphris, S. Whitley, A. Cardozo, and A. Sandhu Smoking habits in patient's who have been treated for an oral cancer: validation of self-report using saliva cotinine Oral Oncol. 40 2004 576 578
23. A. Florescu, R. Ferrence, T. Einarson, P. Selby, O. Soldin, and G. Koren Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology Ther. Drug Monit. 31 2009 14 30
24. G.W. Warren, S.M. Arnold, J.P. Valentino, T.J. Gal, A.J. Hyland, A.K. Singh, and et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population Radiother. Oncol. 103 2012 45 48
25. N.A. Morales, M.A. Romano, K. Michael Cummings, J.R. Marshall, A.J. Hyland, A. Hutson, and et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients Cancer Causes Control 24 2013 1223 1230
26. A.J. Wells, P.B. English, S.F. Posner, L.E. Wagenknecht, and E.J. Perez-Stable Misclassification rates for current smokers misclassified as nonsmokers Am. J. Public Health 88 1998 1503 1509